Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 24898 | 249 | 31.5 | 45% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 892 | 10711 | JOURNAL OF INTERFERON RESEARCH//ISG15//JOURNAL OF INTERFERON AND CYTOKINE RESEARCH |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BIOL GENET BACTERIAL CELL WALL | Address | 1 | 50% | 0% | 1 |
| 2 | FC GAMMA RIII ALPHA | Author keyword | 1 | 50% | 0% | 1 |
| 3 | HUMAN INJECTIONS | Author keyword | 1 | 50% | 0% | 1 |
| 4 | TUMORVIRUS IMMUNOL | Address | 1 | 50% | 0% | 1 |
| 5 | HUMAN EVOLUTIONARY GENET | Address | 0 | 33% | 0% | 1 |
| 6 | IMMUNO ENZYMATIC ASSAY | Author keyword | 0 | 25% | 0% | 1 |
| 7 | MEDIAL TEMPORAL SCLEROSIS | Author keyword | 0 | 20% | 0% | 1 |
| 8 | SKIN WINDOW | Author keyword | 0 | 20% | 0% | 1 |
| 9 | VIRUS TITERS | Author keyword | 0 | 20% | 0% | 1 |
| 10 | UMS20 | Address | 0 | 17% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ENDOGENOUS INTERFERON | 1 | 15% | 2% | 5 |
| 2 | INACTIVATED PERTUSSIS VACCINE | 1 | 50% | 0% | 1 |
| 3 | KUTSCHERI | 1 | 50% | 0% | 1 |
| 4 | BACTERIAL LIPOPOLYSACCHARIDES ENDOTOXINS | 0 | 33% | 0% | 1 |
| 5 | MIXED LYMPHOCYTE | 0 | 33% | 0% | 1 |
| 6 | ASTROCYTOSIS | 0 | 20% | 0% | 1 |
| 7 | C3H HEJ MACROPHAGES | 0 | 20% | 0% | 1 |
| 8 | PROTEIN ICP4 | 0 | 20% | 0% | 1 |
| 9 | PEANUT AGGLUTININ BINDING | 0 | 17% | 0% | 1 |
| 10 | VIRAL RIBONUCLEOTIDE REDUCTASE | 0 | 17% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| MACROPHAGES AND OTHER NONSPECIFIC DEFENSES - ROLE IN MODULATING RESISTANCE AGAINST HERPES-SIMPLEX VIRUS | 1992 | 37 | 66 | 32% |
| LPS GENE-ASSOCIATED FUNCTIONS | 1988 | 5 | 7 | 71% |
| ADJUVANTS - A BALANCE BETWEEN TOXICITY AND ADJUVANTICITY | 1993 | 329 | 116 | 9% |
| MECHANISMS OF INTRINSIC MACROPHAGE VIRUS INTERACTIONS INVITRO | 1990 | 11 | 38 | 29% |
| VIRUSES AND THE VERSATILE MACROPHAGE | 1985 | 100 | 87 | 8% |
| MACROPHAGE OXIDATIVE-METABOLISM - A DEFENSE-MECHANISM AGAINST VIRUS-INFECTION | 1983 | 1 | 1 | 100% |
| FROM BIOTECHNOLOGY TO BACTERIAL TOXINS AND IMMUNOMODULATORS | 1984 | 0 | 17 | 29% |
| THE PRODUCER CELL OF INTERFERON IN MURINE LYMPHOCYTE-CULTURES | 1982 | 0 | 8 | 50% |
| IMMUNOLOGY OF HERPES-SIMPLEX VIRUSES | 1982 | 4 | 10 | 40% |
| HOST DEFENSES IN MICE AGAINST INFECTIONS WITH HERPES-SIMPLEX VIRUS | 1984 | 0 | 17 | 24% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOL GENET BACTERIAL CELL WALL | 1 | 50% | 0.4% | 1 |
| 2 | TUMORVIRUS IMMUNOL | 1 | 50% | 0.4% | 1 |
| 3 | HUMAN EVOLUTIONARY GENET | 0 | 33% | 0.4% | 1 |
| 4 | UMS20 | 0 | 17% | 0.4% | 1 |
| 5 | KINGS NEUROSCI | 0 | 13% | 0.4% | 1 |
| 6 | ADV BIOSYS INC | 0 | 100% | 0.4% | 1 |
| 7 | EXPT PATH | 0 | 100% | 0.4% | 1 |
| 8 | INTEGRAT CLIN | 0 | 100% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000169588 | LPS HYPERSENSITIVITY//CORYNEBACTERIUM PARVUM//NCPP |
| 2 | 0.0000129987 | BACTERIAL INVASIVENESS//BLOOD DERIVED MONOCYTES//BNITM |
| 3 | 0.0000129532 | NEUROBIOL VACCINE DEV//HERPES SIMPLEX KERATITIS//HERPETIC STROMAL KERATITIS |
| 4 | 0.0000111809 | JOURNAL OF INTERFERON RESEARCH//TEXAS REPORTS ON BIOLOGY AND MEDICINE//JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS |
| 5 | 0.0000108793 | MTP PE//LIPOSOMAL MTP PE//L MTP PE |
| 6 | 0.0000108385 | ALPHA TOCOPHEROL THERAPY//COMBINATION PATHOGENETIC THERAPY//GRP DEV MOL DIAGNOST IN IDUALIZED THER Y |
| 7 | 0.0000101805 | NOCARDIA OPACA//BACTERIAL ADJUVANT//STAPHYLOCOCCAL SERINE PROTEINASE |
| 8 | 0.0000099356 | LIVER LECTINS//ADHESIVE CELLS//LECTIN BLOCKING |
| 9 | 0.0000098080 | TOXOPLASMA LYSATE ANTIGEN//OBIOPEPTIDE//L5178Y R LYMPHOMA |
| 10 | 0.0000097210 | B10 MOUSE//LIGHT DARKNESS TEST//INSERMU461 |